Exhibit 10.42

 

Employment Agreement

 

between

 

Thomas Bachmann, Wieslerstrasse 36, CH - 8702 Zollikon

 

“Employee”

 

and

 

Bruker BioSpin AG, Industriestrasse 26, CH - 8117 Fällanden

 

(Handelsregister-Nr.  CH-020.3.924.534-8)

 

“Employer”  or “Company”

 

as well as

 

Bruker Corporation, a Delaware corporation located at 40 Manning Road,
Billerica, Massachusetts 01821, USA

 

“Bruker”

 

Recitals

 

The Employee has on July 29th, 2013 entered into a first employment agreement
with Bruker BioSpin International AG, Aegeristrasse 52, CH - 6300 Zug and
Bruker. The Company and Bruker will based upon this Employment Agreement take
over all rights and obligations of Bruker BioSpin International AG and Bruker
under the first employment agreement, which will cease to be effective, once
this Employment Agreement has been duly signed. Based upon this Employment
Agreement, the Employee will forthwith be employed by the Company and be
appointed by Bruker in a global functional role as

 

Group President

 

of the Bruker BioSpin Group (BBIO Group), which presently consists of the
following two Divisions:

 

·             Bruker BioSpin Magnetic Resonance (MRS) Spectroscopy Division,
with its major operations in Fällanden/CH, Rheinstetten/DE and
Karlsruhe-Rheinhafen/DE, Wissembourg/FR and Billerica, MA (USA).

·             Bruker BioSpin Preclinical Imaging (PCI) Division, with its major
facilities in Ettlingen/DE, Kontich/B and Billerica, MA (USA).

 

The exact composition of this BBIO Group within Bruker could change from time to
time in the future.

 

Emplyoment Agreement THBA / BioSpin AG

[g30242kki001.jpg]

 

--------------------------------------------------------------------------------

 

Employer and Employee hereby agree on the terms and conditions of the Employee’s
employment and certain other matters as follows:

 

1.                                      Commencement of Employment

 

This Employment Agreement becomes effective and shall replace the employment
agreement dated July 29th, 2013 once it has been duly signed by the parties.

 

2.                                      Position, Place of Work

 

2.1                               The Employee will be employed by the Company
and appointed by Bruker as of the Effective Date in an executive position as
Group President of the BBIO Group and shall report to the President and Chief
Executive Officer (“CEO”) of Bruker. The Employee will coordinate strategic or
major decisions within the BBIO Group also with Jörg Laukien, the Executive
Chairman of the BBIO Group.

 

2.2                               The Employee’s place of work shall be at the
Company’s offices in Fällanden / CH. The Employee’s duties require the Employee
to regularly travel on business for the Company or Bruker to other locations
both in Europe and overseas.

 

3.                                      Remuneration

 

The total annual compensation consists of (i) the Base Salary, (ii) the Target
Bonus and (iii) the Long-Term Equity Incentive:

 

3.1                               The Base Salary shall be CHF 360’000
(three-hundred sixty thousand Swiss Francs) per annum, pro-rated for the
remainder of 2013, and for the year 2014, payable in cash with 12 equal monthly
installments, subject to any deductions or withholdings required by Swiss law.
The base salary will be reviewed annually, for the first time in January 2015
for the year 2015.

 

3.2                               The Target Bonus shall be 50% of the Base
Salary, i.e. initially CHF 180’000 for 2014 in cash, subject to an annual goals
achievement review which is based upon achieving key financial metrics of the
annual BBIO Group business plan, and other agreed-upon qualitative goals. Should
the Employee exceed various elements of the annual BBIO Group business plan,
then the target bonus elements can increase linearly, and are presently not
capped.

 

The annual quantitative goals to be achieved will be set either by the Bruker
CEO or the Bruker Board of Directors Compensation Committee, based upon the
annual business plan for the BBIO Group.  Qualitative goals shall be discussed
between the Employee and the CEO and then will be set by the Bruker CEO or the
Bruker Board of Directors Compensation Committee, typically early in the first
quarter of each calendar year.

 

For the period starting on Effective Date until 3lst December 2013, the Employee
shall be entitled to a pro-rated share of the Target Bonus in cash, regardless
of whether the goals of the BBIO Group are achieved, i.e. CHF 66’575 is
guaranteed for the employment period in 2013.

 

The Target Bonus for a given calendar year is typically paid in March of the
following year.

 

3.3                               The Long-Term Equity Incentive (LTEI) shall
consist of Bruker options and/or restricted shares, or similar equity or
equity-like grants, valued at approximately 100% of the annual Base

 

2

--------------------------------------------------------------------------------

 

Salary. It is Bruker’ s intention to make this an annual grant, as it is
understood, that this is an important part of the Employee’s overall annual
compensation, but formally equity grants are at the discretion of the Bruker
Board’s Compensation Committee. Should such a LTEI grant not be made, total
annual compensation will be reviewed.

 

The LTEI grants will typically be awarded in July of each calendar year and be
legally governed by individual Bruker Stock Option and/or Restricted Stock Award
Agreements.

 

The grants will typically consist of a mix of 50% Bruker stock options and 50%
Bruker restricted shares. However, upon Employee’s request, the mix of stock
options can be likely altered up to a ratio of 30% stock options and 70%
restricted shares (in terms of value, not in terms of units).

 

Upon start of the employment at the Effective Date, the Employee shall receive a
one-time start-up grant of 14’000 Bruker restricted shares and 11’400 Bruker
stock options, within weeks of the start of the employment.

 

4.                                      Pension Plan (BVG) and Business Salary
Insurance

 

(BVG = Swiss “Bundesgesetz über die berufliche Alters-, Hinterlassenen- und
Invalidenvorsorge“)

 

4.1                               Employee will participate in the Employer’s
pension fund scheme (BVG), which presently provides insurance protection (life
and disability) and pension coverage for an insured sum that is capped at CHF
130’000 per annum of salary and bonus.

 

4.2                               Employee shall work with Employer and Bruker’s
global HR management to revise the pension coverage so that starting with the
year 2014, the Employee’s pension coverage and protection shall be adequate for
the position and reasonable in cost.

 

4.3                               Employee shall work with Employer and Bruker’s
global HR management to revise insurance coverage for Swiss employees of Bruker,
with the goal of having updated insurance coverage in place before the end of
the year 2013, which is intended to provide for a “Business Salary Insurance”
for a period of up to 720 days that provide adequate coverage in favor of the
Employee, should the Employee be incapable to perform its duties under this
agreement due to illness or accident.

 

4.4                               In addition, in case of Employee’s death, the
Employer shall continue to pay Base Salary for six months.

 

5.                                      Business Travel and Mobile Phone & Data
Devices

 

5.1                               Employee’s air travel shall typically be in
Economy Class within Europe and in Business Class for overseas trips.

 

5.2                               The Employee shall be provided with mobile
phone and mobile data devices for business and reasonable private use /
purposes, whereby all costs shall be borne by the Company.

 

6.                                      Reimbursement of Costs

 

The Company shall reimburse Employee for any business expenses against invoice
and in accordance with expense regulations, if these were reasonably incurred by
the Employee when promoting the business of Bruker.

 

3

--------------------------------------------------------------------------------

 

7.                                      Company Car

 

For the time being, no company car is provided. However, the Company’s car
policy is under review and eligibility will be assessed when appropriate.

 

8.                                      Hours of Work

 

The Employee’s working time shall be commensurate with the tasks and
responsibility of his position. It shall be adapted to the necessities of the
business and the proper conduct of the Company’s and Bruker’s affairs. Any
overtime work or travel outside ordinary business hours shall be deemed
compensated by the remuneration set out above and the Employee shall not be
entitled to any overtime pay or compensation.

 

9.                                      Employee’s General Obligations and
Rights

 

9.1                               The Employee shall faithfully and diligently
perform his tasks, in compliance with the instructions given to him by the CEO
and/or the Board of Directors of Bruker.

 

9.2                               During the entire employment, the Employee
will be required to follow all of the Employer’s and Bruker’s internal policies
and to conduct his business activities at all times in accordance with the
highest legal, ethical and professional standards.

 

9.3                               The Employee shall devote his full working
time to Bruker and shall not undertake other professional activities, whether
paid or unpaid, and/or accept other employments (except for 9.5).

 

9.4                               The Employee shall not establish or maintain
any material form of additional, non-company related business connection with
any customer or supplier of Bruker, or Bruker itself, unless written permission
from an authorized officer of Bruker is obtained prior to the establishment of
such additional business connection (except for 9.5).

 

9.5                               The Employee has Bruker’s permission to accept
one board of directors assignment with a third company, assuming this company
has no conflict of interest with Bruker, and provided the company is Swiss or
German, i.e. there is no excessive travel or periods of absence involved; any
further assignment will have to be discussed with Bruker, which shall not
unreasonably withhold its consent. It is further assumed that the involvement
with such company is normal Board involvement, rather than extensive strategic
consulting, turn-around support or similar.

 

10.                               Vacation & Holidays

 

10.1                        The Employee will be entitled to 30 days of vacation
per annum (if employment starts or ends during the year pro rata).

 

10.2                        In addition, 9 days paid public holidays per
calendar year are granted.

 

11.                               Term and Termination

 

11.1                        This agreement is entered into for a fixed term
until the end of 2014, starting from the Effective Date and shall thereafter
continue to be in effect for an indefinite term until the official Swiss
retirement age, or until the Employer’s 65th birthday, whichever is later.

 

4

--------------------------------------------------------------------------------

 

11.2                        After the Employer’s 65th birthday or the Swiss
retirement age, both parties may optionally extend the employment by written
mutual agreement, as is or in modified form.

 

11.3                        This agreement may - earliest at the beginning of
2015 - be terminated by either party giving six (6) months written notice as per
the end of any calendar month.

 

11.4                        The statutory probation period is waived.

 

12.                               D&O Insurance

 

The Employee shall be covered by Bruker’s Directors & Officers (D&O) Insurance
and Bruker shall, upon the Employee’s request, disclose the policy and any
extension or alteration thereof.

 

13.                               Confidentiality

 

13.1                        The Employee acknowledges and agrees to the fact
that the employment relationship will give him access to the customers and to
business secrets of Bruker and that the use of such knowledge other than for the
benefit of Bruker would significantly damage Bruker.

 

13.2                        The Employee further acknowledges and agrees that as
a result of his employment by the Company, he will become acquainted with other
Bruker employees and their abilities and that such information is proprietary to
Bruker.

 

13.3                        The Employee shall not disclose at any time (except
as the Employee’s Company or Bruker duties may require), either during, or
subsequent to, the Employee’s employment, any technical or business information,
including, but not limited to, electronic circuitry, electronic and mechanical
drawings, measurement methods, manufacturing techniques, software, chemical or
biological techniques or methods, production or sales activities, customer lists
of either existing customers or prospects, inventions, application notes,
research and development reports, present and future business lines or direction
of business or other matters which are of a secret or confidential nature; as
all such and related items are information considered to be of a confidential
nature, and to be Bruker property.

 

13.4                        Upon termination of his employment hereunder (for
whatever reason) and at any other time at Bruker’s request the Employee shall,
without retaining any copies or other record thereof, deliver to Bruker or any
person Bruker may nominate, each and every document and all other material of
whatever nature in the possession or under the control of the Employee
containing or relating directly or indirectly to any Confidential Information.

 

13.5                        The confidentiality undertaking set forth in this
Section 12 shall cease to apply to any information which shall become available
to the public generally otherwise than through the default of the Employee.

 

14.                               Intellectual Property

 

14.1                        All inventions and designs and other proprietary
work effort which the Employee either alone or in conjunction with others
invents, conceives, makes or produces while employed by Bruker (whether during
working hours or not) and which directly or indirectly:

 

(a)         relate to matters within the scope of the Employee’s duties or field
of responsibility; or

 

5

--------------------------------------------------------------------------------

 

(b)         are based on the Employee’s knowledge of the actual or anticipated
business or interests of the Company or any of the Bruker companies; or

 

(c)          are aided by the use of time, materials, facilities or information
of the Company or any of the Bruker companies;

 

and all legal rights therein shall be the sole and exclusive property of Bruker.

 

14.2                        The Employee shall communicate to Bruker promptly,
confidentially and fully all inventions made or conceived by the Employee
(whether made solely by the Employee, or jointly with others) from the time of
entering Bruker’s employment until the Employee leaves Bruker.

 

14.3                        The Employee shall assist, execute and perform at
the expense of Bruker and its nominees both during the continuance of his
employment hereunder and at all times thereafter all such applications,
assignments, documents, acts and things as may reasonably be required by Bruker
for the purpose of obtaining and enforcing in such countries as Bruker may
direct all necessary legal protection in respect of inventions, designs and
other proprietary work effort owned by Bruker and for vesting the same in Bruker
or as Bruker may direct.

 

Such inventions to be and remain the sole and exclusive property of Bruker or
its nominees, whether patented or not.

 

14.4                        The Employee shall make and maintain adequate and
current written records of all such inventions, in the form of notes, sketches,
drawings, or reports relating thereto, which records shall be and remain the
property of and available to Bruker or its nominees at all times.

 

14.5                        The Employee is recognizing that inventions made or
conceived by the Employee relating to the Employee’s activities while working
for Bruker and conceived, reduced to practice, created, derived, developed, or
made by the Employee, alone or with others, within three (3) months after the
termination of the Employee’s employment with Bruker may have been conceived,
reduced to practice, created, derived, developed, or made in significant part
while employed by Bruker, to presume that such inventions have been conceived,
reduced to practice, created, derived, developed, or made during the Employee’s
employment with Bruker and to assign the same promptly to Bruker, unless and
until the Employee establishes to the contrary by written evidence satisfying
the clear and convincing standard of proof.

 

14.6                        The Employee agrees, to notify Bruker in writing
before the Employee makes any disclosure or performs any work for, or on behalf
of, Bruker, which appears to threaten or conflict with:

 

a)    rights that the Employee claims in any invention or idea conceived by the
Employee or others prior to his employment with Bruker, or otherwise outside the
scope of this Agreement; or

 

b)    rights of others arising out of obligations incurred by the Employee prior
to this Agreement, or otherwise outside the scope of this Agreement;

 

In the event of the Employee’s failure to give such notice under such
circumstances, Bruker may assume that no such conflict exists.  The Employee
will make no claim against Bruker with respect to the use of any such invention
or idea in the Employee’s work which the Employee performs or causes to be
performed for or on behalf of Bruker.

 

6

--------------------------------------------------------------------------------

 

15.                               Personal Data Protection

 

With the execution of this Agreement, the Employee consents that the Company may
store, transfer, change and delete all personal data in connection with this
employment relationship. In particular, the Employee consents to the transfer of
personal data concerning the Employee by the Company to an affiliated company of
Bruker outside Switzerland. Bruker agree to keep all personal data of the
Employee strictly confidential.

 

16.                               Non-Competition and Non-Solicitation

 

16.1                        The Employee shall not work for, consult for, or
otherwise provide services for, a competitor of the BBIO Group for one (1) year
after the termination for any reason of the Employee’s employment with the
Company.  A competitor of the BBIO Group is narrowly defined as any for profit
company or entity which manufactures, designs, markets, consults on or sells any
types of magnetic resonance- (MR), superconducting magnet-, computer aided
tomography- (CT), positron-emission tomography- (PET) or optical imaging- (OI)
instrumentation for use in biology, chemistry, physics or materials research, or
for pre-clinical imaging (everything except human in vivo imaging) applications
that the BBIO Group represents. Employee agrees that the above non-compete
restrictions cover much less than 5% of the analytical instruments industry.

 

16.2                        The Employee shall not, during the period of the
Employee’s employment with the Company and for a period of two (2) years after
the termination thereof, either directly or indirectly, separately or in
association with others, interfere with, impair, disrupt or damage the BBIO
Group’s (a) relationship with any of its customers or customer prospects by
soliciting or encouraging others to solicit any of them for the purpose of
diverting or taking away business from the BBIO Group; or (b) business by
soliciting, encouraging or attempting to hire any of the BBIO Group’s employees
or causing others to solicit or encourage any of the BBIO Group’s employees to
discontinue their employment with the BBIO Group.

 

17.                               General Provisions

 

17.1                        All notices shall be addressed to the other party at
the address specified at the beginning of this Agreement, or to any other
address as provided by the parties through subsequent written notice.

 

17.2                        This Agreement constitutes the entire agreement and
understanding among the parties with respect to the employment of the Employee
with the Company, and shall supersede all prior oral and written agreements or
understandings of the parties relating hereto (in particular the duly signed
Offer Letter, dated June 15th 2013 with Bruker).

 

Any representation or statement (in whatever form) made to the Employee in
connection with the Employee’s employment not incorporated in this Agreement
shall not be valid and have no effect.

 

17.3                        This Agreement may only be modified or amended in a
written form signed by the Employee and an officer or authorized executive of
the Company or Bruker. Any provision contained in this Agreement may only be
waived by a document signed by the party waiving such provision. No waiver of
any violation or non-performance of this Agreement in one instance shall be
deemed to be a waiver of any violation or non-performance in any other instance.
All waivers must be in writing.

 

7

--------------------------------------------------------------------------------

 

17.4                        If any provision of this Agreement is found by any
competent authority to be void, invalid or unenforceable, such provision shall
be deemed to be deleted from this Agreement and the remaining provisions of this
Agreement shall continue in full force. In this event, the Agreement shall be
construed, and, if necessary, amended in a way to give effect to, or to
approximate, or to achieve a result which is as close as legally possible to the
result intended by the provision hereof determined to be void, illegal or
unenforceable.

 

17.5                        This Agreement shall be binding upon the Employee’s
heirs, executors, administrators, legal representatives and assigns.

 

17.6                        The Employee represents that he has no agreements
with, or obligations to, others in conflict with the foregoing.

 

18.                               Governing Law and Jurisdiction

 

18.1                        This Agreement, shall be governed by, interpreted
and construed in accordance with the substantive laws of Switzerland.

 

18.2                        Exclusive jurisdiction for all disputes arising out
of or in connection with this Agreement shall be with the competent courts of
the Canton of Zürich.

 

        “        

 

Billerica, MA (USA),

 

Fällanden (CH),

 

Zollikon (CH),

December 3rd, 2013

 

December 3rd, 2013

 

December 3rd, 2013

 

 

 

 

 

 

 

 

 

 

For Bruker:

 

For Employer:

 

Employee:

 

 

 

 

 

By:

/s/ Frank H. Laukien

 

By:

/s/ Jörg Laukien

 

By:

/s/ Thomas Bachmann

Frank H. Laukien

 

Jörg Laukien

 

Thomas Bachmann

President & CEO

 

Executive Chairman, BBIO Group

 

 

Bruker Corporation

 

on behalf of Bruker BioSpin AG

 

 

 

8

--------------------------------------------------------------------------------